The DOI matches its Crossref record; 164 of the 165 references it cites were found in a registry or an index.
Risk factors for childhood and adult primary brain tumors
Open accessAbstract
Primary brain tumors account for ~1% of new cancer cases and ~2% of cancer deaths in the United States; however, they are the most commonly occurring solid tumors in children. These tumors are very heterogeneous and can be broadly classified into malignant and benign (or non-malignant), and specific histologies vary in frequency by age, sex, and race/ethnicity. Epidemiological studies have explored numerous potential risk factors, and thus far the only validated associations for brain tumors are ionizing radiation (which increases risk in both adults and children) and history of allergies (which decreases risk in adults). Studies of genetic risk factors have identified 32 germline variants associated with increased risk for these tumors in adults (25 in glioma, 2 in meningioma, 3 in pituitary adenoma, and 2 in primary CNS lymphoma), and further studies are currently under way for other histologic subtypes, as well as for various childhood brain tumors. While identifying risk factors for these tumors is difficult due to their rarity, many existing datasets can be leveraged for future discoveries in multi-institutional collaborations. Many institutions are continuing to develop large clinical databases including pre-diagnostic risk factor data, and developments in molecular characterization of tumor subtypes continue to allow for investigation of more refined phenotypes. Key Point 1. Brain tumors are a heterogeneous group of tumors that vary significantly in incidence by age, sex, and race/ethnicity.2. The only well-validated risk factors for brain tumors are ionizing radiation (which increases risk in adults and children) and history of allergies (which decreases risk).3. Genome-wide association studies have identified 32 histology-specific inherited genetic variants associated with increased risk of these tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The other types include pituitary tumors, pineal gland tumors, ependymomas, craniopharyngiomas, lymphomas, germ cell tumors, and schwannomas [87].”
From A Comprehensive Analysis of Recent Deep and Federated-Learning-Based Methodologies for Brain Tumor Diagnosis (2022) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella‐Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,703
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Ostrom, Q. T., Gittleman, H. R., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz‐Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 12,063
Self-citationSocioeconomic Inequalities in Health in 22 European Countries
Mackenbach, J. P., Stirbu, I., Roskam, A.-J. R., Schaap, M. M., Menvielle, G., Leinsalu, M., & Kunst, A. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa0707519 · Cited by 3,289
The epidemiology of glioma in adults: a "state of the science" review
Ostrom, Q. T., Bauchet, L., Davis, F. G., Deltour, I., Fisher, J. L., Langer, C. E., Pekmezci, M., Schwartzbaum, J., Turner, M. C., Walsh, K. M., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou087 · Cited by 2,320
Self-citationOstrom, Q. T., Gittleman, H. R., Truitt, G., Boscia, A. L., Kruchko, C., & Barnholtz‐Sloan, J. S. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy131 · Cited by 2,163
Self-citationObesity and cancer risk: Emerging biological mechanisms and perspectives
Avgerinos, K. I., Spyrou, N., Mantzoros, C. S., & Dalamaga, M. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.001 · Cited by 1,567
Epidemiology and etiology of gliomas
Ohgaki, H., & Kleihues, P. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-0991-y · Cited by 1,285
The whole-genome landscape of medulloblastoma subtypes
Northcott, P. A., Buchhalter, I., Morrissy, A. S., Hovestadt, V., Weischenfeldt, J., Ehrenberger, T., Gröbner, S., Segura-Wang, M., Zichner, T., Rudneva, V. A., et al. (2017) · Nature · doi:10.1038/nature22973 · Cited by 1,112
Identification of seven loci affecting mean telomere length and their association with disease
CARDIoGRAM consortium, Codd, V., Nelson, C. P., Albrecht, E., Mangino, M., Deelen, J., Buxton, J. L., Hottenga, J. J., Fischer, K., Esko, T., et al. (2013) · Nature Genetics · doi:10.1038/ng.2528 · Cited by 933
Research works printed but not linked: 5
- Chen, 2019, Two novel genetic variants in the STK38L and RAB27A genes are associated with glioma susceptibility, Int J Cancer, 10.1002/ijc.32179 · DOI
- Porter, 2015, Socioeconomic status and glioblastoma risk: a population-based analysis, Cancer Causes Control, 26, 179, 10.1007/s10552-014-0496-x · DOI
- Khanolkar, 2016, Socioeconomic position and the risk of brain tumour: a Swedish national population-based cohort study, J Epidemiol Community Health, 10.1136/jech-2015-207002 · DOI
- Clegg, 2009, Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: national longitudinal mortality study, Cancer Causes Control, 20, 417, 10.1007/s10552-008-9256-0 · DOI · Paper page
- Disney-Hogg, 2018, Influence of obesity-related risk factors in the aetiology of glioma, Br J Cancer, 118, 1020, 10.1038/s41416-018-0009-x · DOI
Cited by
Sorted by citations
Ostrom, Q. T., Cioffi, G., Gittleman, H. R., Patil, N. T., Waite, K. A., Kruchko, C., & Barnholtz‐Sloan, J. S. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz150 · Cited by 2,660
Self-citationOstrom, Q. T., Patil, N., Cioffi, G., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa200 · Cited by 1,789
Self-citationGlioblastoma and Other Primary Brain Malignancies in Adults
Schaff, L. R., & Mellinghoff, I. K. (2023) · JAMA · doi:10.1001/jama.2023.0023 · Cited by 1,411
Ostrom, Q. T., Price, M., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C., & Barnholtz-Sloan, J. S. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad149 · Cited by 1,294
Self-citationCancer statistics for adolescents and young adults, 2020
Miller, K. D., Fidler‐Benaoudia, M., Keegan, T. H., Hipp, H. S., Jemal, A., & Siegel, R. L. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21637 · Cited by 1,190
Wen, P. Y., Weller, M., Lee, E. Q., Alexander, B. M., Barnholtz-Sloan, J. S., Barthel, F. P., Batchelor, T. T., Bindra, R. S., Chang, S. M., Chiocca, E. A., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa106 · Cited by 1,168
Brain and other central nervous system tumor statistics, 2021
Miller, K. D., Ostrom, Q. T., Kruchko, C. A., Patil, N. T., Tihan, T., Cioffi, G., Fuchs, H. E., Waite, K. A., Jemal, A., Siegel, R. L., et al. (2021) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21693 · Cited by 1,004
Self-citationPrice, M., Ballard, C. A. P., Benedetti, J. R., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C. A., Barnholtz‐Sloan, J. S., & Ostrom, Q. T. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae145 · Cited by 547
Self-citationGlioblastoma: clinical presentation, diagnosis, and management
McKinnon, C., Nandhabalan, M., Murray, S. A., & Plaha, P. (2021) · BMJ · doi:10.1136/bmj.n1560 · Cited by 419
Ostrom, Q. T., Price, M., Ryan, K. J., Edelson, J. L., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C. A., & Barnholtz‐Sloan, J. S. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac161 · Cited by 324
Self-citationMiller, J. J., Castro, L. N. G., McBrayer, S. K., Weller, M., Cloughesy, T. F., Portnow, J., Andronesi, O. C., Barnholtz‐Sloan, J. S., Baumert, B. G., Berger, M. S., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac207 · Cited by 265
Price, M., Ballard, C. A. P., Benedetti, J. R., Kruchko, C. A., Barnholtz‐Sloan, J. S., & Ostrom, Q. T. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf194 · Cited by 199
Self-citationEpidemiology of Brain and Other CNS Tumors
Ostrom, Q. T., Francis, S. S., & Barnholtz‐Sloan, J. S. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01152-9 · Cited by 198
Self-citationCounts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019
Siegel, D. A., King, J., Lupo, P. J., Durbin, E. B., Tai, E. W., Mills, K., Dyne, E. A. V., Lunsford, N. B., Henley, S. J., & Wilson, R. J. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad115 · Cited by 170
Wu, Y., Deng, Y., Wei, B., Xiang, D., Hu, J., Zhao, P., Lin, S., Zheng, Y., Yao, J., Zhai, Z., et al. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.06.001 · Cited by 139
Pediatric Brain Tumors: Descriptive Epidemiology, Risk Factors, and Future Directions
Fahmideh, M. A., & Scheurer, M. E. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1443 · Cited by 109
Self-citationNaeem, A., Anees, T., Naqvi, R. A., & Loh, W.-K. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020275 · Cited by 103
Dewdney, B., Jenkins, M. R., Best, S. A., Freytag, S., Prasad, K., Holst, J., Endersby, R., & Johns, T. G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01637-8 · Cited by 107
Epidemiology, risk factors, and prognostic factors of gliomas
Pellerino, A., Caccese, M., Padovan, M., Cerretti, G., & Lombardi, G. (2022) · Clinical and Translational Imaging · doi:10.1007/s40336-022-00489-6 · Cited by 96
Mesenchymal stem cell-derived exosomes as a new therapeutic strategy in the brain tumors
Ghasempour, E., Hesami, S., Movahed, E., Keshel, S. H., & Doroudian, M. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03212-4 · Cited by 97
Signaling pathways in brain tumors and therapeutic interventions
Li, S., Wang, C., Chen, J., Lan, Y., Zhang, W., Kang, Z., Zheng, Y., Zhang, R., Yu, J., & Li, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01260-z · Cited by 105
Updates in IDH-Wildtype Glioblastoma
Melhem, J. M., Detsky, J. S., Lim-Fat, M. J., & Perry, J. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01251-6 · Cited by 101
Wen, P. Y., Weller, M., Lee, E. Q., Touat, M., Khasraw, M., Rahman, R. M., Platten, M., Lim, M. K., Winkler, F., Horbinski, C., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf177 · Cited by 113
Self-citationImpact of age and gender on glioblastoma onset, progression, and management
Colopi, A., Fuda, S., Santi, S., Onorato, A., Cesarini, V., Salvati, M., Balistreri, C. R., Dolci, S., & Guida, E. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111801 · Cited by 96
The role of gut microbiota in patients with benign and malignant brain tumors: a pilot study
Jiang, H., Zeng, W. G., Zhang, X., Pei, Y., Zhang, H., & Li, Y. (2022) · Bioengineered · doi:10.1080/21655979.2022.2049959 · Cited by 82
Jiao, Y., Yang, L., Wang, R., Song, G., Fu, J., Wang, J., Gao, N., & Wang, H. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121611 · Cited by 63
Xu, H., Han, Y., Zhao, G., Zhang, L., Zhao, Z., Wang, Z., Zhao, L., Hua, L., Konduru, N., Lu, J. L., et al. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c12971 · Cited by 62
Exposure to nitrate from drinking water and the risk of childhood cancer in Denmark
Stayner, L. T., Schullehner, J., Semark, B. D., Jensen, A. S., Trabjerg, B. B., Pedersen, M., Olsen, J., Hansen, B., Ward, M. H., Jones, R. R., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106613 · Cited by 64
Hamblin, R., Vardon, A., Akpalu, J., Tampourlou, M., Spiliotis, I., Sbardella, E., Lynch, J. M., Shankaran, V., Mavilakandy, A. K., Gagliardi, I., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00160-7 · Cited by 59
Cotache-Condor, C. F., Kantety, V., Grimm, A., Williamson, J., Landrum, K. R., Schroeder, K., Staton, C. A., Majaliwa, E., Tang, S., Rice, H. E., et al. (2022) · Pediatric Blood & Cancer · doi:10.1002/pbc.30175 · Cited by 67
Qader, S. M., Hassan, B. A., & Rashid, T. A. (2022) · Multimedia Tools and Applications · doi:10.1007/s11042-022-13260-w · Cited by 47
Applications of organoid technology to brain tumors
Wen, J., Liu, F., Cheng, Q., Weygant, N., Liang, X., Fan, F., Li, C., Zhang, L., & Liu, Z. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14272 · Cited by 44
Gatto, N. M., Ogata, P., & Lytle, B. (2021) · Cancers · doi:10.3390/cancers13174477 · Cited by 39
Chen, L., Ma, J., Zou, Z., Liu, H., Liu, C., Gong, S., Gao, X., & Liang, G. (2022) · Medicine · doi:10.1097/md.0000000000032042 · Cited by 39
MiRNAs as major players in brain health and disease: current knowledge and future perspectives
Kapplingattu, S. V., Bhattacharya, S., & Adlakha, Y. K. (2025) · Cell Death Discovery · doi:10.1038/s41420-024-02283-x · Cited by 44
Sex-specific aspects of epidemiology, molecular genetics and outcome: primary brain tumours
Rhun, É. L., & Weller, M. (2020) · ESMO Open · doi:10.1136/esmoopen-2020-001034 · Cited by 32
Crosstalk Between the Gut and Brain: Importance of the Fecal Microbiota in Patient With Brain Tumors
Li, Y., Jiang, H., Wang, X., Liu, X., Huang, Y., Wang, Z., Ma, Q., Dong, L., Qi, Y., Zhang, H., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.881071 · Cited by 33
Viruses in glioblastoma: an update on evidence and clinical trials
Gunasegaran, B., Ashley, C. L., Marsh‐Wakefield, F., Guillemin, G. J., & Heng, B. (2024) · BJC Reports · doi:10.1038/s44276-024-00051-z · Cited by 32
Huang, Y.-K., Chang, K., Li, C., Lieu, A., & Lin, C. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45040222 · Cited by 32
Understanding Neovascularization in Glioblastoma: Insights from the Current Literature
Ballato, M., Germanà, E., Ricciardi, G., Giordano, W. G., Tralongo, P., Buccarelli, M., Castellani, G., Ricci‐Vitiani, L., D’Alessandris, Q. G., Giuffrè, G., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062763 · Cited by 34
Madlener, S., Stepien, N. M., Senfter, D., Mayr, L., Laemmerer, A., Hedrich, C., Baumgartner, A., Lötsch-Gojo, D., Štěrba, J., Pokorná, P., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-024-02842-7 · Cited by 28
Iron Transporters and Ferroptosis in Malignant Brain Tumors
Zhao, J., Wang, Y., Tao, L., & Chen, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.861834 · Cited by 28
Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma
Chen, Y., Zhao, C., Li, S., Wang, J., & Zhang, H. (2023) · Cancers · doi:10.3390/cancers15030602 · Cited by 28
Gut microbiota and their influence in brain cancer milieu
BharathwajChetty, B., Kumar, A., Deevi, P. I., Abbas, M., Alqahtani, A., Liang, L., Sethi, G., Liu, L., & Kunnumakkara, A. B. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03434-2 · Cited by 34
Simionescu, N., Zonda, R., Petrovici, A. R., & Georgescu, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13070988 · Cited by 28
Kim, S., Son, Y., Oh, J., Kim, S., Jang, W., Lee, S., Smith, L., Pizzol, D., Lee, J., Lee, H., et al. (2025) · Journal of Neuro-Oncology · doi:10.1007/s11060-025-05164-0 · Cited by 25
Liu, A. P. Y., Liu, Q., Shing, M. M. K., Ku, D. T. L., Fu, E. C. H., Luk, C., Ling, S.-C., Cheng, K. K. F., Kwong, D. L. �., Ho, W. W.-S., et al. (2020) · JCO Global Oncology · doi:10.1200/jgo.19.00378 · Cited by 25
Nrf2/Keap1/ARE regulation by plant secondary metabolites: a new horizon in brain tumor management
Dewanjee, S., Bhattacharya, H., Bhattacharyya, C., Chakraborty, P., Fleishman, J. S., Alexiou, A. T., Papadakis, M., & Jha, S. K. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01878-2 · Cited by 29
Racial/ethnic and sex differences in young adult malignant brain tumor incidence by histologic type
Monterroso, P. S., Moore, K. J., Sample, J. M., Sorajja, N., Domingues, A. M., & Williams, L. A. (2021) · Cancer Epidemiology · doi:10.1016/j.canep.2021.102078 · Cited by 24
Horta, M., Soares, P., Pereira, C. L., & Lima, R. T. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17020142 · Cited by 25
Gajjar, A. J., Mahajan, A., Bale, T., Bowers, D. C., Canan, L., Chi, S. N., Cluster, A. S., Cohen, K. J., Cole, B., Coven, S. L., et al. (2025) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2025.0012 · Cited by 23
Associations of General and Abdominal Obesity with the Risk of Glioma Development
Ahn, S., Han, K., Lee, J., Jeun, S., Park, Y., & Yang, S.-H. (2021) · Cancers · doi:10.3390/cancers13122859 · Cited by 23
Nikmanesh, Y., Mohammadi, M. J., Yousefi, H., Mansourimoghadam, S., & Taherian, M. (2022) · Reviews on Environmental Health · doi:10.1515/reveh-2022-0033 · Cited by 24
Huang, J., Li, H., Yan, H., Li, F.-X., Tang, M., & Lu, D. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1018836 · Cited by 22
Epidemiology and survival of adult-type diffuse glioma in Belgium during the molecular era
Pinson, H., Silversmit, G., Vanhauwaert, D. J., Vanschoenbeek, K., Okito, J.-P. K., Vleeschouwer, S. D., Boterberg, T., & Gendt, C. D. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad158 · Cited by 28
Pathology of the Tumors of the Central Nervous System
Bumci, R., Parthymos, I., Zamboglou, C., & GOUSSIA, A. C. (2023) · Springer eBooks · doi:10.1007/978-3-031-33517-4_6 · Cited by 22
The Epidemiology of Brain and Spinal Cord Tumors
Shobeiri, P., Seyedmirzaei, H., Kalantari, A., Mohammadi, E., Rezaei, N., & Hanaei, S. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-14732-6_2 · Cited by 20
Yang, W., Cai, Y., Chen, J., Yang, P., Ying, Z., Liang, Y., Ling, M., Zhu, K., Sun, H., Ji, Y., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1067858 · Cited by 20
Causes of Childhood Cancer: A Review of the Recent Literature: Part I—Childhood Factors
Ricci, A. M., Emeny, R. T., Bagley, P. J., Blunt, H. B., Butow, M. E., Morgan, A., Alford‐Teaster, J., Titus, L. J., Walston, R. R., & Rees, J. R. (2024) · Cancers · doi:10.3390/cancers16071297 · Cited by 24
Ge, C., Li, J., Liu, L., Liu, H., & Qian, Y. (2021) · The Analyst · doi:10.1039/d1an00457c · Cited by 19
Stanić, D., Grujičić, D., Pekmezovic, T. D., Bokun, J., Popović-Vuković, M., Janić, D., Paripović, L., Ilić, V., Slović, M. P., Ilić, R., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259095 · Cited by 19
Diagnostic and therapeutic approach of artificial intelligence in neuro-oncological diseases
Venkatesan, D., Elangovan, A., Babu, H. W. S., Pasha, M. T., Abraham, K. S., Satheeshkumar, J., Sivaprakash, P., Ayyadurai, N., Gopalakrishnan, A. V., Narayanasamy, A., et al. (2022) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2022.100188 · Cited by 19
Ahn, S., Han, K., Park, Y., Bae, J. M., Kim, S. U., Jeun, S., & Yang, S.-H. (2020) · Cancers · doi:10.3390/cancers12051343 · Cited by 19
Subtyping Brain Diseases from Imaging Data
Wen, J., Varol, E., Yang, Z., Hwang, G., Dwyer, D., Kazerooni, A. F., Lalousis, P. A., & Davatzikos, C. A. (2023) · Neuromethods · doi:10.1007/978-1-0716-3195-9_16 · Cited by 19
Förster, A., Brand, F. J., Banan, R., Hüneburg, R., Weber, C. A. M., Ewert, W., Kronenberg, J., Previti, C., Elyan, N., Beyer, U., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02307-1 · Cited by 17
Foss-Skiftesvik, J., Li, S., Rosenbaum, A., Hagen, C. M., Stoltze, U. K., Ljungqvist, S., Hjalmars, U., Schmiegelow, K., Morimoto, L. M., de Smith, A. J., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad042 · Cited by 17
Maimaiti, A., Tuersun, M., Wang, X., Mijiti, M., Wu, H., Cong, C., Wang, Z., & Wang, Y. (2024) · Neuroepidemiology · doi:10.1159/000541917 · Cited by 16
Bauchet, L., Rigau, V., Mathon, B., & Darlix, A. (2024) · Neurochirurgie · doi:10.1016/j.neuchi.2024.101627 · Cited by 19
Cancer Incidence and Etiology in the Active Duty Population of U.S. Military
Lovejoy, L. A., Shriver, C. D., & Ellsworth, R. E. (2022) · Military Medicine · doi:10.1093/milmed/usac297 · Cited by 16
Li, G., Xiao, H., Li, W., & Luo, Y. (2023) · Machine Intelligence Research · doi:10.1007/s11633-022-1392-6 · Cited by 16
The evolutionary impact of childhood cancer on the human gene pool
Stoltze, U. K., Foss-Skiftesvik, J., Hansen, T. V. O., Rasmussen, S., Karczewski, K. J., Wadt, K., & Schmiegelow, K. (2024) · Nature Communications · doi:10.1038/s41467-024-45975-9 · Cited by 17
Pediatric glioma and medulloblastoma risk and population demographics: a Poisson regression analysis
Muskens, I. S., Feng, Q., Francis, S. S., Walsh, K. M., McKean‐Cowdin, R., Gauderman, W. J., de Smith, A. J., & Wiemels, J. L. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa089 · Cited by 16
Self-citationAthanasiou, E., Gargalionis, A. N., Boufidou, F., & Tsakris, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052250 · Cited by 17
Nanoparticle-Based Approaches in the Diagnosis and Treatment of Brain Tumors
Pourmasoumi, P., Banihashemian, S. A., Zamani, F., Rasouli‐Nia, A., Mehrabani, D., & Karimi‐Busheri, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237449 · Cited by 18
Ghose, P., & Jamil, H. M. (2025) · Biomedical Journal · doi:10.1016/j.bj.2025.100871 · Cited by 15
Baenas, N., Vega-García, A., Manjarrez-Marmolejo, J., Moreno, D. A., & Feria-Romero, I. A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115720 · Cited by 15
Alpen, K., Vajdic, C. M., MacInnis, R. J., Milne, R. L., Koh, E., Hovey, E. J., Harrup, R. A., Bruinsma, F., Nguyen, T. L., Li, S., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac279 · Cited by 14
Kojimahara, N., Yoshitake, T., Ono, K., Kai, M., Bynes, G., Schüz, J., Cardis, E., & Kesminiene, A. (2020) · Journal of Radiological Protection · doi:10.1088/1361-6498/abacff · Cited by 16
Sharifian, M. J., Igland, J., Klungsøyr, K., Engeland, A., Zhou, A., & Bjørge, T. (2024) · Cancer Epidemiology · doi:10.1016/j.canep.2024.102524 · Cited by 13
Biomimetic nanoparticle-driven strategies for targeted drug delivery in glioblastoma
Panchal, K. N., Mutalik, S., & Manikkath, J. (2024) · Journal of Nanoparticle Research · doi:10.1007/s11051-024-06104-1 · Cited by 16
Cosnarovici, M. M., Cosnarovici, R., & Piciu, D. (2021) · Medicine and Pharmacy Reports · doi:10.15386/mpr-1811 · Cited by 14
Foss-Skiftesvik, J., Hagen, C. M., Mathiasen, R., Adamsen, D., Bækvad‐Hansen, M., Børglum, A. D., Nordentoft, M., Werge, T. M., Christiansen, M., Schmiegelow, K., et al. (2020) · Child s Nervous System · doi:10.1007/s00381-020-04946-3 · Cited by 13
Reyes, J. S., Estupiñan-Pepinosa, D. F., Leal-Giraldo, S. I., Cordoba-Gallego, M. F., Silva-López, M. P., Aguirre-Patiño, J. S., Gordillo-Iriarte, L. S., Cabezas, C. S., Vega-Alvear, R. F., & Navarro‐Ramirez, L. M. (2026) · Neuroradiology · doi:10.1007/s00234-026-03976-z · Cited by 13
Sita, G., Graziosi, A., Hrelia, P., & Morroni, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011201 · Cited by 13
Cotache-Condor, C. F., Grimm, A., Williamson, J., Kantety, V., Landrum, K. R., Schroeder, K., Staton, C. A., Majaliwa, E., Rice, H. E., & Smith, E. R. (2022) · Pediatric Blood & Cancer · doi:10.1002/pbc.29646 · Cited by 12
Chang, K., Teng, C. J., Hsu, Y., Tsai, S. C., Lin, H.-J., Hsieh, T.-L., Muo, C., Hsu, C. Y., & Chou, R. (2022) · Toxics · doi:10.3390/toxics10040176 · Cited by 12
Nguyen, H. D. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116356 · Cited by 12
Male origin microchimerism and brain cancer: a case–cohort study
Kamper‐Jørgensen, M., Jakobsen, M. A., Tjønneland, A. M., Skjøth‐Rasmussen, J., Petersen, G. L., & Hallum, S. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04494-0 · Cited by 10
Current progress of anti‑PD‑1/PDL1 immunotherapy for glioblastoma (Review)
Wu, J., & Wang, N. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13344 · Cited by 13
Zhao, X., He, M., Yang, R., Geng, N., Zhu, X., & Tang, N. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1574614 · Cited by 11
HLA polymorphisms and risk of glioblastoma in Koreans
Choi, S.-S., Choi, H., Baek, I., Park, S. A., Park, J., Kim, T., Jeun, S., & Ahn, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260618 · Cited by 11
Sha, Y., Yan, Q., Tan, Y. Q., Wang, X., Zhang, H., & Yang, G. (2023) · Cancers · doi:10.3390/cancers15051440 · Cited by 11
Advances in the systemic therapy for recurrent meningiomas and the challenges ahead
Li, Y., & Drappatz, J. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2254498 · Cited by 11
Cioffi, G., Coté, D. J., Ostrom, Q. T., Kruchko, C. A., & Barnholtz‐Sloan, J. S. (2020) · Neuro-Oncology Practice · doi:10.1093/nop/npaa001 · Cited by 11
Self-citationFahmideh, M. A., Peckham‐Gregory, E. C., Schraw, J. M., Chintagumpala, M., Mack, S. C., Lupo, P. J., & Scheurer, M. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-88385-3 · Cited by 11
Self-citationHou, X., Song, Z., Zhang, F., Liu, Z., Long, W., Long, Z., Zhou, M., Wang, E., Yin, P., & Zhu, M. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-059699 · Cited by 11
Weber, C. A. M., Krönke, N., Volk, V., Auber, B., Förster, A., Trost, D., Geffers, R., Esmaeilzadeh, M., Lalk, M., Nabavi, A., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01689-5 · Cited by 10
Mangiaterra, S., Boffetta, P., & Seyyedsalehi, M. S. (2025) · Cancer Epidemiology · doi:10.1016/j.canep.2025.102779 · Cited by 10
Kashani, H. R. K., Alizadeh, P., Salimi, S., Habtemariam, S., Khayatkashani, M., & Tewari, D. (2021) · Child s Nervous System · doi:10.1007/s00381-021-05363-w · Cited by 10
PATZ1 Induces Apoptosis through PUMA in Glioblastoma
Tao, X., Zhang, G., Liu, J., Ji, B., Xu, H., & Chen, Z. (2022) · Journal of Oncology · doi:10.1155/2022/4953107 · Cited by 10
Metadata
- Authors
- Ostrom, Q. T., Fahmideh, M. A., Cote, D. J., Muskens, I. S., Schraw, J. M., Scheurer, M. E., & Bondy, M. L.
- Affiliations
- Baylor College of Medicine (US)
- Karolinska University Hospital (SE)
- Channing Division of Network Medicine, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA
- University of Southern California (US)
- Corresponding author
- Ostrom, Quinn T
- ORCID
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-07-12
- Volume
- 21
- Issue
- 11
- Pages
- 1357-1375
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- PMC
- PMC6827837
- OpenAlex
- W2961422708
- Cited by
- 314
- References
- 165
- Citations by year
- 2026: 29 · 2025: 54 · 2024: 68 · 2023: 64 · 2022: 49 · 2021: 35 · 2020: 13 · 2019: 2
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neuro-Oncology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cancer Prevention and Research Institute of Texas (RP160097T)
- National Institutes of Health (T32 CA 009001, R01CA194189)
- Takeda Pharmaceutical Company Limited (115766)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Oncology › Brain Metastases and Treatment
- Keywords
- primary brain tumors, pediatric brain tumors, adult brain tumors, risk factors, ionizing radiation exposure, allergy history, germline genetic variants, glioma, meningioma, pituitary adenoma, primary central nervous system lymphoma, tumor histology, genome-wide association study
- MeSH terms
- Adult, Brain Neoplasms, Child, Humans, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review